Nicholas Syn

Dean's Fellow, Adj Asst Professor @NUS Medicine
ML/AI in molecular & digital pathology
Website:

[Nicholas Syn @Nicholas_Syn]

Encouraged to be listed again among the Top 2% of Scientists ranking published by @Stanford and @ElsevierConnect for the 2nd year running, based on citations received during calendar year 2022😃

https://t.co/9Y8MTcPR3s

@NUSMedicine @NUSingapore @NUSResearch

[Ching-Hui SIA @chinghuisia]

Glad to have mentored @yaoneng_teo Phase V @NUSMedicine medical student in his undergraduate research opportunities programme project to clinch the only excellence award! Happy to see juniors have their work recognised. @yaohao_teo @Nicholas_Syn @Tonyli1992 @KianKPoh1 @chanyymark

[Nicholas Syn @Nicholas_Syn]

Join us on January 19, 2024, 9 am EST, for the next @_ILTS_ Vanguard Webinar which will focus on liver tx pathology! This lecture is targeted to patient-fronting clinicians (hepatologists, transplant surgeons, and oncologists)

Register here: https://t.co/CkmXvXuFBC

[Abdul Hakeem PhD, FRCS @Abdul_Hakeem_99]

Another exciting ILTS Vanguard webinar!! To increase utilisation of marginal organs, we need help from pathologists. So let’s hear from the experts on “Liver Transplant Pathology-Snapshot of Cases” on Jan 19th 👍 @RyanChadha1 @Nicholas_Syn @_ILTS_

https://t.co/9OCX9StUW3

[Nicholas Syn @Nicholas_Syn]

Always lovely to catch up with the first mentor who set me down this path, Prof Goh Boon Cher 😁
Wishing everyone a fantastic 2024! 😇

[Nicholas Syn @Nicholas_Syn]

Join us on January 19, 2024, 9 am EST, for the next @_ILTS_ Vanguard Webinar which will focus on liver tx pathology! This lecture is targeted to patient-fronting clinicians (hepatologists, transplant surgeons, and oncologists)

Register here: https://t.co/CkmXvXuFBC

[Cheng Han Ng @ChengHanNg]

#LiverTwitter #GITwitter Ep14 from @TheLiverFound marks an important episode that shares the effect of diet and nutrition in #NAFLD and the importance of #diet #intervention with Prof Manuel Romero Gomez! Listen free today!

🎧https://t.co/D0hVp5w29L
📷https://t.co/4eBVe58iir

[Cheng Han Ng @ChengHanNg]

#GITwitter #LiverTwitter 🔥 #Ultrasound and #MRI is used for screening #HCC... but how is the overall quality of both modality for #HCC screening🤔? @Nicholas_Syn @DrHuangDQ @DrLoomba @DrMarkMuthiah

Free to read!: https://t.co/fkGxhNQ6vC !

[Benjamin Tan @DrBenjaminTan]

Metrics are not the best reflection of scientific output.. but was encouraged to be recognised for the second year running on the World’s top 2% most cited researchers list which was initiated by Stanford University and published by Elsevier.

https://t.co/UkDA67teKD

[Cheng Han Ng @ChengHanNg]

#LiverTwitter #GITwitter latest episode at the liver lounge shares a discussion on the latest @BritSocGastro guidelines in #cirrhosis! 🔥🔥

Listen free today!

https://t.co/D0hVp5w29L

https://t.co/4eBVe58iir

[Varia Kirchner @KirchnerVaria]

https://t.co/yuIEhxMh8J @_ILTS_ @ILTSJC @Rela_Institute @dbalci @kymwatt @TomoTanakaLTx @AShinginaMD @Nicholas_Syn @mikespiro All five consensus papers are published on SFSS in LDLT! @StanfordAbdTxp

[The Liver Foundation @TheLiverFound]

#GITwitter #LiverTwitter Our team @TheLiverFound newly led global study on #NAFLD in #T2DM! The synergistic effect of NAFLD and DM 📈the risk of complications, so how many % of #DM have #NAFLD and #NASH? ❗️
➡️https://t.co/9GML9sD1nI

[Rohit Loomba @DrLoomba]

Thanks for highlighting our collaborative work @Filip_Knop ! @ChengHanNg @Gut_BMJ @emadelomar

[Daniel Huang @DrHuangDQ]

🔥off the press @NatRevGastroHep

#HCC surveillance a/w ⬆️ survival

▶️Severely underutilized (<25% in cirrhosis)

▶️ NASH and alcohol 🚀+ a/w unique challenges

▶️ Mitigating strategies available

▶️ Novel biomarkers emerging

@EASLedu @AASLDtweets

https://t.co/9t89zvAC6i

[VCU Stravitz-Sanyal Institute for Liver Disease @VCU_Liver]

🆕Article in press @JHeptaology by @NUSingapore and @VCU_Liver researchers. Natural history of# NASH #cirrhosis in #livertransplant waitlist registrants
Read it here👉https://t.co/txoZO1X0cO
@WenHuiLim4 @VCUTransplant #LiverTwitter

[Cheng Han Ng @ChengHanNg]

#GITwitter #LiverTwitter🔥✅ Latest episode of our podcast from @TheLiverFound has been released! This week, we talk to @DrHuangDQ on the implications of #NAFLD/#MASLD on #HCC🔥Listen free now on your fav podcast application! https://t.co/D0hVp5w29L

[Cheng Han Ng @ChengHanNg]

#LiverTwitter #GITwitter 🔥🔥 happy to share the latest episode by @TheLiverFound with Prof Vincent Chen from Michigan on #MASH (#NASH) related Cirrhosis and it’s implications! Listen now at:

🎧 https://t.co/D0hVp5w29L

🎧 https://t.co/yvCHDwRUYd

[Cheng Han Ng @ChengHanNg]

#GITwitter #LiverTwitter 🔥Happy to share our study in @Gut_BMJ with prof @DrLoomba on the🌐 prevalence of #NAFLD in #T2DM. ➡️35.54% had F2-4, 14.95% had F3-4 within #NAFLD, and up to 23.62% with F3-4 in #NASH.❗️Important to reduce the global burden! https://t.co/sqCNgKh3qX

[Nicholas Syn @Nicholas_Syn]

Humbled to serve as a member of the International Judging Panel for the @sgSMU Lee Kuan Yew Global Business Plan Competition #LKYGBPC

[Joseph J Zhao @josephjzhao]

Standby poster job complete ✅ (with extra freebies 🤪) #WCLC2023